RBM10 is an RNA-binding protein that regulates alternative splicing (AS). This protein localizes to the extra-nucleolar nucleoplasm and S1-1 nuclear bodies (NBs). We investigated the biological significance of RBM10 localization to S1-1 NBs, which is poorly understood.
Introduction 8 deletion analysis. Only the ZnF deletion mutant localized weakly to S1-1 NBs (Fig. 4B ). To confirm that the ZnF possesses NB-targeting activity, the cysteine residues critical for ZnF function at aa 683 and 686 were substituted with alanine or the histidine residue at aa 699 was substituted with serine [Figs 3 (2) and 4C]. The localizations of these two ZnF mutants to S1-1 NBs were weaker than those of parental NB2 and the after-ZnF deletion mutant (D afterZnF). However, the ZnF mutants still localized weakly to S1-1 NBs due to the presence of NBTS1. The second NBTS in the ZnF region was called NBTS2 [Fig. 3 (2) ].
Verification of NBTS1 and NBTS2
As shown above, the NB-targeting activity of NB2 was retained upon single deletion of NBTS1 (KEKE region) or NBTS2 (C2H2 ZnF). Importantly, NB2 did not clearly localize to S1-1 NBs upon simultaneous deletion of both NBTSs [ Fig. 5A (1)], demonstrating their synergistic action in NB localization.
Using ImageJ Plot Profile, NB localization was analyzed in a more quantitative manner. RBM10 does not localize to the nucleolus (Inoue et al., 2008) ; thus, analysis was performed using lines that traversed the extra-nucleolar region [Fig. 5A (2) ]. In contrast with NB2 and D after-ZnF, the NB2 mutants lacking the KEKE region (NBTS1) or the C2H2 ZnF region (NBTS2) showed blunt peaks, and the double deletion mutant showed no distinct peaks. Consistently, the number of S1-1 NBs larger than 0.5 µm decreased upon deletion of NBTSs [ Fig. 5A (3) ]. The results indicate that NBTS1 and NBTS2 synergistically enhance NB localization.
The NBTSs were further verified by employing clones that expressed the KEKE or C2H2 ZnF region linked to the FLAG sequence. In contrast with the control octamer repeat sequence (OCRE), KEKE and C2H2 ZnF localized to S1-1 NBs (Fig. 5B ). Based on these results, we conclude that both the KEKE region (NBTS1) and the C2H2 ZnF region (NBTS2) possess NB-targeting activity.
The C2H2 ZnF is essential for the AS function of RBM10
RBM10 regulates AS. We assessed whether the identified NBTSs are associated with this function of RBM10. Wild-type RBM10 and RBM10 harboring mutations in NBTS1 (KEKE region) or NBTS2 (C2H2 ZnF) were expressed in RBM10-knockout HepG2 cells and their AS activities in pre-mRNA splicing of fas were examined. In this system, wild-type RBM10 causes skipping of exon 6 in fas pre-mRNA (Inoue et al., 2014) . pre-mRNA splicing of fas was not affected by mutation of the critical KEKKE sequence in the KEKE region/NBTS1 to AAKAA, but was almost completely abolished by mutation of the CLLC sequence in the C2H2 ZnF/NBTS2 to ALLA (Fig. 6 , see also Fig. 3 ), demonstrating that the C2H2 ZnF is essential for regulation of AS by RBM10. Importantly, these results also indicate that the C2H2 ZnF has two functions: regulation of AS and localization of RBM10 to S1-1 NBs.
RBM10 does not participate in the structural organization of S1-1 NBs
The possibility that RBM10 localizes to S1-1 NBs and participates in the formation of these structures was examined. We previously showed that RNA is stored in nuclear domains called TIDRs (transcription-inactivation-dependent RNA domains) when HeLa cells are injected with Cy3-labeled ftz model pre-mRNA and successively incubated with actinomycin D (Act D) (Tokunaga et al., 2006) and that TIDRs and S1-1 NBs are the same structural entities (Inoue et al., 2008) . Using this experimental system, we examined whether S1-1 NBs/TIDRs formed in the absence of RBM10. For this purpose, RBM10 was knocked down using specific siRNAs in HeLa cells (Fig. 7a ), Cy3-labeled ftz pre-mRNA was introduced into cells, and cells were incubated with Act D. S1-1 NBs/TIDRs formed even in the absence of RBM10, as visualized by Cy3 fluorescence of ftz RNA (Fig. 7b) . Thus, we conclude that RBM10 does not participate in the structural organization of S1-1 NBs.
RBM10 is transiently sequestered in S1-1 NBs when transcription is reduced
We previously showed that localization of RBM10 to S1-1 NBs is closely associated with reduced transcription (Inoue et al., 2008) . When cells were incubated with Act D, the localization of RBM10 to S1-1 NBs increased in a time-dependent manner. These NBs became larger and fewer in number [ Fig. 8A (1)]; however, the cellular level of RBM10 does not change upon incubation with Act D (Inoue et al., 2008) . Enlarged S1-1 NBs also form upon heat shock, serum starvation, and confluent cell culture, where cellular transcriptional activity is commonly decreased, and upon treatment with the RNA polymerase II (pol II) inhibitor a-amanitin (Inoue et al., 208) . We verified these previous results using other pol II inhibitors, namely, flavopiridol and 5,6-dichloro-1-b-D-ribo-furanosylbenzimidazole (DRB)
[ Fig. 8A (2) ]. These reagents inhibit CDK9, the kinase subunit of the positive transcription elongation factor P-TEFb, which is essential for productive transcription (Chao and Price, 2001 ). These two inhibitors were examined because flavopiridol also inhibits the cell cycle kinases CDK1 and CDK4, while DRB also inhibits casein kinase II (CK2) (Meggio et al., 1990 , Bensaude, 2011 . RBM10 accumulated in S1-1 NBs upon treatment with either inhibitor [ Fig. 8A (2) ], suggesting that this accumulation was due to inhibition of P-TEFb. In support of this, the effects of DRB [ Fig. 8A (2)] were not replicated by treatment with the potent CK2 inhibitor LY294002 (Gharbi et al., 2007) or knockdown of CK2 with specific siRNAs (data not shown). Thus, the formation of enlarged S1-1 NBs upon treatment with flavopiridol and DRB is due to their inhibition of P-TEFb, and RBM10 accumulates in S1-1 NBs when transcription is arrested.
The changes in S1-1 NBs were reversible. When cells were washed with fresh medium, the enlarged S1-1 NBs formed in the presence of a-amanitin or DRB returned to their initial state within 4 and 1 h, respectively [ Fig. 8A (2) ]. The difference in the amount of time required to reverse the effect is likely due to differences in the affinities of these inhibitors for their binding sites or because a-amanitin also triggers pol II degradation (Nguyen et al, 1996) . (2)]. Thus, the localization of RBM10 to S1-1 NBs changes in a dynamic and reversible manner according to the level of cellular transcriptional activity, without a change in the protein level of RBM10. The dynamic and reversible localization of RBM10 to S1-1 13 NBs, as well as the finding that RBM10 does not participate in the formation of S1-1 NBs (Fig. 7) , indicate that RBM10 is a transient component of S1-1 NBs and is sequestered in these structures when cellular transcription decreases. These results also suggest that S1-1 NB sequesters proteins, in addition to other possible functions.
Discussion
The present study demonstrates that RBM10 has two NBTSs, called NBTS1 and NBTS2, which are located in the KEKE motif and C2H2 ZnF regions, respectively. Each NBTS alone can target and localize to S1-1 NBs; however, both are required for increased localization of RBM10 to S1-1 NBs. Thus, NBTS1 and NBTS2 act in a synergistic manner. NBTS1 and NBTS2 are separated by approximately 110 aa residues and have no sequence homology (Figs 1 and 3). Thus, these NBTSs likely interact with spatially close but distinct structures within S1-1 NBs, the geometry of which seems to enable their synergistic action.
Under reduced transcription conditions, RBM10 localizes to S1-1 NBs and these structures become enlarged. When transcriptional activity is restored, enlarged S1-1 NBs return to their initial state and RBM10 leaves from these structures (Inoue et al, 2008, and Fig. 8 ). The present study showed that RBM10 does not participate in the formation of S1-1 NBs and that the cellular level of RBM10 is maintained upon inhibition of transcription and 14 during the subsequent chase period. These findings indicate that RBM10 is a transient component of S1-1 NBs and is stored or sequestered in these structures when transcription decreases.
The identified NBTSs were sufficient for localization of RBM10 to S1-1 NBs. All known NBs, including S1-1 NBs (Inoue et al., 2008) , are membrane-less compartments (for a review, Mao et al., 2011) ; therefore, we suggest that targeting and localization of transient NB proteins to NBs are based on the association of specific sequences of the proteins, here NBTSs, with acceptor sites in NBs. This may be obvious, but it is worth noting.
The C2H2 ZnF/NBTS2 was bi-functional: it was not only important for NBtargeting/localization, but was also essential for regulation of AS by RBM10. Hernández et al. (2016) reported that deletions from the C-terminus, including the G-patch and C2H2 ZnF, result in progressive and partial loss of the AS regulatory activity of RBM10, indicating that the integrity of RBM10 is required for its full function. Our results support this previous study and further demonstrate that substitution of the two critical cysteine residues of the C2H2 ZnF with alanine was sufficient to completely abolish the AS regulatory activity of RBM10 (Fig.   6 ).
How the ZnF performs the dual functions of NB-targeting and AS regulation is an intriguing question. When transcription is suppressed, the level of nucleoplasmic pre-mRNAs 15 decreases and the C2H2 ZnF no longer binds to its substrates or the splicing machinery complex, which functions together with RBM10. This unoccupied state seems to induce the NB targeting activity of the C2H2 ZnF, thereby increasing the localization of RBM10 to S1-1 NBs. Thus, the C2H2 ZnF likely acts as a sensor to enhance sequestration of RBM10 in S1-1 NBs.
The RBM10 gene resides on the X chromosome, and one of its copies is inactivated by X-inactivation in females (Coleman, et al., 1996 , Thiselton, et al., 2002 , Goto and Kimura, 2009 ). This implies that a double dose of RBM10 is unfavorable to cells and that the cellular level of active RBM10 must be controlled. In this regard, sequestration of RBM10 in S1-1 NBs may be a mechanism to rapidly and efficiently regulate the active nucleoplasmic level of RBM10. Specifically, RBM10 is promptly released from S1-1 NBs and localizes to transcription/splicing sites in the nucleoplasm when transcription increases, while it is stored in S1-1 NBs when transcription decreases. This sequestration may prevent excessive RBM10 from engaging in unfavorable AS of irrelevant pre-mRNAs, which would produce products that elicit unfavorable effects on cells.
Dysfunction of RBM10 leads to various diseases. Specific defects in NBTS activity may also cause RBM10-related diseases. Further studies are required to elucidate the molecular mechanisms that regulate sequestration of RBM10 in S1-1 NBs, including the identification and characterization of the acceptor sites for RBM10 in S1-1 NBs and the resident core proteins that comprise S1-1 NBs.
Experimental procedures
Cells and cell culture. HeLa cells derived from human cervical carcinoma, HepG2 cells derived from human hepatocellular carcinoma, and HEK293T cells derived from human embryonic kidney and transformed with the SV40 large T-antigen were cultured in Dulbecco's Modified Eagle Medium (Nissui). ARL cells (rat liver epithelial cells; Japan Health Sci. Found., JCRB0248) were cultured in Williams' Medium E (Gibco BRL). The media were supplemented with 5% fetal calf serum (Gibco BRL), 100 µg/mL streptomycin, and 100 IU/mL penicillin. Fetal calf serum was used at a concentration of 10% for culture of HepG2 cells. In inhibition experiments, ARL cells were incubated with 5 µg/mL Act D, 50 µg/mL a-amanitin, 0.5 mM DRB, or 0.2 µM flavopiridol.
Immunostaining. Immunofluorescence analysis was performed as described previously (Inoue et al., 2008) . RBM10 and S1-1 NBs were stained with anti-S1-1 antiserum (Inoue et al., 2008 ; 1:250 working dilution) and rhodamine-conjugated goat anti-rabbit IgG (1:200 dilution; ICN, 55662). Stained cells were examined using a fluorescence microscope (Olympus, type IX70; numerical aperture, 0.4; and objective lens, ×20). Data were captured using image acquisition software (DP Controller). Images were processed for contrast and/or brightness.
Immunoblotting. Western blotting was performed as previously described (Inoue et al., 2008) . Total proteins (equivalent to 0.2 µg of cellular DNA) were electrophoresed on 10% sodium dodecyl sulfate-polyacrylamide gels (e-PARGEL; Atto).
Primers, RBM10 mutant plasmids, and transfection. The PCR primers used to prepare the various constructs are listed in Table S1 . Each primer contained a restriction sequence at one end. The PCR conditions were as follows: elongation (30 cycles, 5 s/kb) at 72°C, denaturation (10 s) at 95°C or 98°C, and annealing (15 s) at 3.5-5.0°C below the lower Tm of each primer set. PCR products were digested with the corresponding restriction enzymes, purified, and ligated into pEGFP-N1, pEGFP-C3 (Clontech), or p3xFLAG-Myc-CMV-24 (Sigma-Aldrich).
Competent JM109 Escherichia coli cells (Takara) were transformed with the constructs, the resulting colonies were cultured, and recombinant plasmids were isolated using the Pure Yield Plasmid Miniprep System (Promega). The sizes and DNA sequences of the purified plasmids were verified by agarose gel electrophoresis and sequencing with a 3130x1 DNA Sequencer (ABI), respectively. Transfection was performed using Lipofectamine LTX and PLUS Reagent (Invitrogen) according to the manufacturer's recommendations.
Constructs and mutagenesis of RBM10.
The constructs ND1, ND11, and ND15, and that encoding aa 1-469 were produced by sequential deletion from pS1-1/EGFP-N1 (Inoue et al., 2008) as described previously (Xiao et al., 2013) . To generate pNB1/EGFP-C3 and pNB2/EGFP-C3, sequences encoding aa 476-645 and aa 476-760 of RBM10 were PCRamplified and ligated into the SacI and PstI sites of pEGFP-C3. Deletion or substitution mutagenesis of these plasmids was performed using a PrimeSTAR Mutagenesis Basal Kit (Takara) and the primers listed in Table S1 . The sequences encoding aa 475-533, the KEKE region (aa 529-590 or aa 529-571), and the C2H2 ZnF region (aa 676-711) were similarly amplified (Table S1 ) and ligated into the HindIII and KpnI sites of the p3xFLAG-Myc-CMV-24 vector. The two KEKE constructs yielded similar results.
RBM10 knockdown.
HeLa cells were transfected with 40 nM specific human RBM10-siRNA5 or control AllStar siRNA (Qiagen) using Lipofectamine 2000 (Invitrogen) and incubated for 3 days, in accordance with the manufacturer's protocol. A second specific siRNA, which was designed to target a different region of RBM10 mRNA, yielded similar results, indicating that the results obtained were not due to an off-target effect.
Nuclear injection of ftz pre-mRNA. Cy3-labeled ftz pre-mRNA was microinjected into the nuclei of HeLa cells at approximately 80% confluency using a Microinjector 5170 (Eppendorf) as previously described (Tokunaga et al., 2006) . Cells were incubated for 2 h in (Aravind and Koonin, 1999; Sloan and Bohnsack, 2018) .
The OCRE, KEKE motif, and amphipathic a-helix (AHH) are described in Fig. 3. 
B.
Presence of an NBTS within aa 415-742. Plasmids ND1, ND11, and ND15 were derived from pS1-1(RBM10)/EGFP-N1 by deleting the regions corresponding to aa 2-4, 4-414, and 4-742, respectively, and expressed in ARL cells. Green, EGFP; red, RBM10 stained with anti-S1-1 antiserum. Some S1-1 NBs are indicated by arrows. Scale bar: 10 µm. (1) KEKE region. Alternating positive and negative aa residues in the KEKE region are indicated by boldface. "Amphi a-helix" is a region predicted to form a perfect AAH with five helical turns (Inoue et al., 1996) . (2) C2H2 ZnF. The cysteine and histidine residues critical for ZnF function are highlighted by boldface. (3) OCRE (octamer repeat, also called NLS3).
Brackets 1-5 represent the five repeating octamers (8 aa) originally assigned based on hydrophilicity/hydrophobicity profiles (Inoue et al., 1996) . The aa 486-540 region (aa 564-618 of the 930-aa isoform) forms a globular domain with an anti-parallel b-sheet fold (Martin et al., 2016) . A. NB localization of NB2 and its mutants. (1) The KEKE region (aa 524-598), the C2H2 ZnF region (aa 685-703), both the KEKE and C2H2 ZnF regions, or the after-ZnF region (aa 711-742) were deleted from pNB2/EGFP-C3 and these constructs were expressed in ARL cells.
Green: EGFP. Some S1-1 NBs and nucleoli are indicated by arrows and arrowheads, respectively. (2) Analysis by ImageJ Plot Profile. The nuclear distributions of the mutants were analyzed along the indicated lines, which traversed the extra-nucleolar nucleoplasm and S1-1 NBs. (3) Number of S1-1 NBs. NBs larger than 0.5 µm were counted by two individuals independently using enlarged images of cells (Fig. S2) , and the numbers were averaged. B.
Verification of the NB-targeting activity of the KEKE region and C2H2 ZnF. Sequences encoding the KEKE region (aa 529-590), the C2H2 ZnF (aa 676-711), and the control OCRE region (aa 475-533) were PCR-amplified, ligated to the FLAG-tag in p3xFLAG-Myc-CMV-24, and expressed in ARL cells. Cells were stained with an antibody against FLAG (green), and nuclei were counterstained with 4´,6-diamidino-2-phenylindole (blue). Scale bar: 10 µm. 
